This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Gamma Knife Market

Increase in the Number of Cancer Patients to Surge the Demand for Gamma Knife. FMI Presents Detailed Analysis to Understand the Potential in 30+ Countries

Gamma Knife Market by Disease Indication, Anatomy & Region – Forecast 2023–2033

Gamma Knife Market Outlook (2023-2033)

The global gamma knife market is expected to grow at a CAGR of 5.7% during the period 2023-2033. The market holds a valuation of US$ 343.1 million as of 2023, and by 2033, the market is expected to reach a valuation of US$ 600 million.

The key factors expected to drive the adoption of gamma knife surgeries include:

  • Increase preference toward non- and minimally-invasive procedures
  • High success rate of Gamma Knife treatment
  • Positive perception among healthcare providers
  • Focus on developed novel treatment procedures for neurological disorders
  • Comprehensive health insurance cover radiation therapy

There has been an increase in neurological disorders worldwide, which has led to increasing demand for non-invasive procedures. Based on the statistics, there is an increase in neurological disorders, especially among the geriatric population. This is expected to surge the demand for gamma knife during the forecast period.

Apart from that, an increase in the number of cancer cases worldwide is also expected to increase the market share of gamma knife during the forecast period. Based on a survey conducted by cancer.org, by 2040, the world might witness over 27.5 million new cancer cases and 16. Million cancer deaths. Moreover, based on research published by the American Cancer Society, brain cancer is considered the third highest cause of death among people aged 40 plus. Thus, proactive measures taken by people experiencing even the lightest of symptoms are expected to have a positive effect on the gamma knife adoption trends.

Furthermore, growing technological advancements in the healthcare sector are expected to further surge the market share. The gamma knife makes use of computer guided treatment device, which allows the surgeons to perform the operation with higher precision. The ability to deliver strong radiation beams to treat brain tumours and lesions, arteriovenous malformations, acoustic neuroma, tremors, and trigeminal neuralgia is expected to further increase the sales of gamma knife going ahead.

Apart from being a non-invasive procedure, the patients do not experience any pain while undergoing the procedure. This is because of the fact that no damage to the nearby cell is caused in this process which makes it relatively seamless. Furthermore, there are no side effects involved in the process, which makes it one of the most highly sought-after procedures in the current times.

On the back of exhaustive research on its efficacy and high success rate, Gamma Knife continues to gain traction among healthcare centres as a highly effective radiosurgery system. Linear Accelerator (LINAC) remains the widely used radiation therapy treatment procedure – nearly 50% of patients undergoing radiation therapy were treated using LINAC.

Gamma Knife and Cyber Knife are the two widely used stereotactic radiation therapy procedures. The global gamma knife equipment revenues were estimated at US$ 172 million in 2015, and since then, the product has been successful in gaining a decent amount of traction.

Attributes

Value

Gamma Knife Market Value (2022)

US$ 313.8 million

Gamma Knife Market Value (2023)

US$ 343.1 million

Gamma Knife Market Forecast Value (2033)

US$ 600 million

Gamma Knife Market Expected CAGR (2023 to 2033)

5.7%

Customize this Report

Let us know your requirement to get
100% FREE customization

Historical CAGR (2017-2022) vs Anticipated CAGR: Way Ahead for Gamma Knife Market

On comparing the historical CAGR with the anticipated CAGR, we would get a sense of what might lead to a leaner patch during the forecast period. While the historical CAGR for the market was nearly 9%, the anticipated CAGR is 5.7%. The availability of affordable alternatives might have led to the reduction of CAGR.

However, in certain parts of the world, the drug authorities have started giving them clearances and are personally in favour of their usage. For example, in the USA, Elekta announced that Elekta Esprit, a new Leksell gamma knife radiosurgery platform, received FDA 510(k) clearance. This milestone makes the system available to clinicians and people with brain disease in the U.S., as well as opening the door to other countries where FDA approval is recognized.

Rising Obesity Worldwide to Surge Gamma Knife Market

Surging obesity cases worldwide are expected to be one of the key growth factors for the gamma knife market. The surgeons are motivating obese patients to opt for the gamma knife method for treating obesity, as it is a non-invasive procedure. Based on a survey conducted, non-invasive procedures account for more than 50% of the aesthetic medicine market share, which represents massive scope for the gamma knife market.

Apart from that, governments worldwide are investing huge amounts in promoting non-invasive procedures in order to ensure complete wellness for their citizens. This is owing to the fact that gamma knife surgery makes use of the latest technology, and the technological upgradation would certainly be in sync with healthcare improvement.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Imaging Software Implementation to spur Massive Growth

Growing methodical use of integrated imaging software to keep a constant check on the amount of dose delivery is expected to fuel demand for gamma knife in the assessment period. The market will also gain from the rapid development of radiation devices and innovations to ensure minimal invasions and reduced post-surgical complications in surgery.

Some of the leading companies are focusing on innovations to offer advanced patient care. For instance, Elekta, a key leader in precision radiation medicine, announced the launch of its new Leksell Gamma Knife Lightning, a leading-edge innovation for intracranial stereotactic radiosurgery. This innovation completely aligns with Elekta’s developmental strategy focused on contributing to the healthcare sector by enhancing operational efficiency, minimizing drafting time and equipping physicians to concentrate significantly on patient-centric care.

Increased Collaborations to present Massive Opportunities

Increased focus on acquisitions and collaborations is expected to increase in the coming years and might act as one of the key trends impacting the gamma knife industry. For instance, Brainlab, a digital medical technology company, announced the acquisition of Mint Medical GmbH, a medical technology company proficient in manufacturing image reading and reporting software for clinical routine and research.

The acquisitions will foster growth in the automation of radiology reports through AI anatomical mapping and formulation of holistic data. Apart from that, one of the key reasons behind adopting this strategy is to increase the market share and make use of maximum resources to develop the best quality gamma knife.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

High Cost to Challenge Market Growth

The high cost of the gamma knife procedure might be one of the main reasons why the growth rate of the market has been cut down for the forecast period. The cost of a Gamma Knife is in the range of US$ 4 Mn to US$ 5 Mn, with additional setup costs of US$ 1 Mn to US$ 2 Mn. Total investment in procuring a machine can add up to US$ 7 Mn. The high cost of Gamma Knife has remained a longstanding challenge. However, it is expected that technological advancement will lead to cost reduction in the future.

Apart from that, the lack of availability of equipment in a lot of developing and underdeveloped countries might also pose a challenge. This coupled with the lack of knowledge about the existence of such a procedure, is expected to have a negative impact on the gamma knife adoption trends. Moreover, fluctuating reimbursement rates and a scarcity of skilled professionals are factors expected to hamper market growth.

Comparative View for Gamma Knife Market

Gamma Knife Market:

Attributes

Gamma Knife Market

Anticipated CAGR (2023 to 2033)

5.7%

Market Value (2023)

US$ 343.1 million

Growth Factor

Increase in cancer and neurological disorder

Future Opportunities

Increased collaborations amongst key players

Market Trends

Surging adoption of gamma knife for treating obesity

Liposuction Market:

Attributes

Liposuction Market

Anticipated CAGR (2023 to 2033)

6.8%

Market Value (2023)

US$ 5.2 billion

Growth Factor

Reduction in stigma associated with cosmetic reconstruction

Future Opportunities

Increase in adoption of minimally invasive procedures

Market Trends

Increasing celebrity endorsements

Cancer Tissue Diagnostics Market:

Attributes

Cancer Tissue Diagnostics Market

Anticipated CAGR (2023 to 2033)

6.6%

Market Value (2023)

US$ 5.8 billion

Growth Factor

Increase in the cancer cases

Future Opportunities

High emphasis on individualised cancer treatment

Market Trends

Technological upgradation in the healthcare sector

Country-wise Analysis

Country United States
CAGR (2023-2033) 6.3%
Historical CAGR (2017-2022) 9%
Absolute Dollar Growth US$ 68.7 Mn
Country United Kingdom
CAGR (2023-2033) 5.9%
Historical CAGR (2017-2022) 9.3%
Absolute Dollar Growth US$ 11.5 Mn
Country Japan
CAGR (2023-2033) 4.6%
Historical CAGR (2017-2022) 8.5%
Absolute Dollar Growth US$ 18 Mn
Country China
CAGR (2023-2033) 5.7%
Historical CAGR (2017-2022) 9.5%
Absolute Dollar Growth US$ 62.8 Mn
Country South Korea
CAGR (2023-2033) 4.3%
Historical CAGR (2017-2022) 8.2%
Absolute Dollar Growth US$ 10.5 Mn

Surging Cancer Cases to Drive USA Market

The USA market is expected to reach a valuation of US$ 150.9 million by the end of 2033. An increase in the number of cancer cases is supposedly driving the market growth in the country. Based on the data of Cancer Data and Statistics, more than 1.7 million cancer cases were reported in the USA alone.

Furthermore, the gamma knife treatment is a non-invasive form of treatment, which makes it preferable over a lot of other methods. Apart from that, an increasing disposable income is expected to further drive the market growth as it makes the process affordable. Furthermore, as per the statistics collected by FMI, the North America region is the largest market for gamma knife, and the USA market has the largest share of close to 53.5% in the North America region.

UK Market Driven by Huge Parkinson’s disease

The UK market is expected to reach a valuation of US$ 26.4 million by the end of 2033. The market is mainly driven by an increase in the number of patients suffering from Parkinson’s disease. As of 2022, more than 145,000 people are suffering from Parkinson’s in the country.

Apart from that, even the key players who are into gamma knife are making use of the latest technology to improvise the existing versions. They have been funding researchers to bring about innovative practices. With the study detailing the treatment planning of brain metastases for 35 brain lesions from 20 patients, researchers developed treatment plans using cyclotron and LIGHT proton systems as well as the photon systems such as gamma knife radiosurgery.

China Market Riding High on Obese Patients

The China market is expected to reach a valuation of US$ 148.5 million by the end of 2033. A massive surge in the number of obese patients is expected to drive the China market during the forecast period.

Based on a survey conducted, the cosmetic reconstruction market in China is expected to grow at a massive 30% during the forecast period. As a part of this process, a lot of people undergo fat removal procedures through gamma knife surgery. This is expected to surge the market share in China during the forecast period.

Vascular Abnormalities in Japan expected to Surge Market Growth

The Japan market is expected to reach a valuation of US$ 49.4 million by 2033. An increase in the number of cases pertaining to vascular abnormalities is expected to surge the market share. There are a number of people in the region who suffer from problems caused within the veins and the arteries owing to the lifestyle they lead.

Apart from that, the healthcare sector in Japan has been witnessing massive technological upgradation. This has certainly helped with the evolution of the gamma knife market as a result of which the key players are able to keep themselves a notch ahead as compared to players from other regions.

Government Initiatives driving the South Korea Market

The South Korean government has been taking a number of initiatives to ensure the best possible healthcare for its people. Korean public healthcare covers between 50-80% of medical costs depending on the individual’s needs and the treatment they receive. This includes the costs for medical checkups, general procedures, accident coverage, and prescription medication.

This, coupled with the high disposable income of an average South Korean individual, is expected to surge the gamma knife market share during the forecast period. Apart from that, the collaborations between the key players in the healthcare sector and the Korean government are expected to further surge the market share.

Segmentation Analysis

Segment Name Disease Indication
Top performing sub segment Brain metastasis
Historical CAGR (2017-2022) 8.8%
Segment Name Anatomy
Top performing sub segment Head
Historical CAGR (2017-2022) 8.6%

Brain Metastasis Sub-Segment Expected to grow at 5.4%

Brain metastasis holds the highest market share based on the disease indication segment. An increase in the number of cancer cases, especially cerebrum malignancy, and an upgradation of the medical infrastructure are expected to surge the market share of the brain metastasis segment.

A survey conducted by WHO found that cancer was the leading cause of death worldwide in 2020, and around 10 million people died of cancer. The point to be noted over here is that brain cancer forms a major chunk of the market share. Apart from that, when a patient reaches stage 4 cancer, there is a high chance that cancer developed in a body part might spread to the brain as well. All these factors are expected to further surge the market share.

Head to Surge at a CAGR of 5.1%

The higher share of the head segment can be attributed to an increase in the adoption of the non-invasive techniques in general. The adoption rate tends to become higher when treating brain tumour. Apart from that, the side effects involved while undergoing the procedure is almost nil.

Furthermore, the usage of computer guided treatment equipment ensures that the operation is carried out with the highest efficiency. This coupled with the high precision at which the beam strikes the target area ensures that the success rate remains high as compared to a lot of other procedures.

Ability to offer Single or Fractioned Radiation Therapy Driving the Start-up Space

The start-ups operating in the gamma knife market are giving clinicians devices to perform single or fractioned frame-based or frameless radiation therapy. Apart from that, the start-ups are also making use of the radiosurgery method in gamma knife therapy, where the radiation beams are powerfully concentrated at the target. This is done without affecting the healthy tissue.

Apart from that, the start-ups are making use of noncoplanar beams instead of shaped beams, which makes it possible to move some or all shots. This, along with the usage of a 0.15 mm resolution screen, has been developed by the start-ups operating in this space to develop the best quality gamma knife system.

Competitive Landscape

The key players operating in the gamma knife market are implementing predictive service business, which has resulted in important strides in their offerings. The technology implemented by them helps proactively identify linear accelerator component issues that could result in unscheduled downtime. For example, Elekta Care™ Support Services has been making use of the above techniques to make a positive impact on patient care.

Top manufacturers of gamma knife market

Name Elketa
Company Description

Elketa is driven by a united PURPOSE that motivates the company and as individuals to keep alive the “Hope for everyone dealing with cancer”. The company is driven by the VISION – “A world where everyone has access to the best cancer care”. The company has been planning to get there through our MISSION – “We improve patient lives by working together with our customers and partners.”

As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible.

Latest News in gamma knife market In November 2022, the Swedish and the Jordanian royalty inaugurated the Elekta radiation therapy devices for cancer and brain disease.
Name Varian Medical Systems
Company Description

Varian Medical System has been dedicated to forging a new, more unifying, smarter standard of oncology - connecting us all through more intelligent data, insights, and solutions to realize our vision of a world without fear of cancer.

From software and machines to patient data and core teams, Varian’s Intelligent Cancer Care is uniting the world’s cancer fight.

Varian hosts several webinar series, covering topics ranging from thought leadership/emerging ideas in oncology to the safe and effective use of Varian technology.

Latest News in gamma knife market In November 2022, Varian Medical Systems announced the first participant treated in GENESIS clinical III trial of Genicular Artery Embolisation for Knee Osteoartritis.
Name Akesis
Company Description

Akesis is focused on ensuring everyone has access to life-saving Radiation Medicine. By combining innovative, advanced technology with proven treatment approaches, Akesis has created the next evolution in Radiation Medicine.

Our platform-based development approach allows Akesis to meet the needs of everyone from small rural centers to large academic health systems. Because we are unburdened by legacy designs, we have been free to innovate and improve.

Latest News in gamma knife market In March 2022, Akesis and Macromedics explored advances in head and neck positioning. They recently completed usability testing with a specially designed version of the MacroMedics Double Shell Positioning System (DSPS®) on the Akesis Galaxy® RTi.

Key Companies in Gamma Knife Market

  • Elekta,
  • Varian Medical Systems,
  • Huiheng Medical, Inc.,
  • Akesis, Inc

Gamma Knife Market Segmentation

By Disease Indication:

  • Brain Metastasis,
  • Cancer,
  • Arteriovenous Malformation,
  • Trigeminal Neuralgia,
  • Others

By Anatomy:

  • Head,
  • Neck,
  • Other Body Parts

By Region:

  • North America
  • Latin America
  • APAC
  • MEA
  • Europe

Frequently Asked Questions

The global gamma knife market holds a valuation of US$ 343.1 million as of 2023.

The gamma knife market is expected to grow at 5.7% CAGR during 2023-2033.

The global gamma knife market is forecasted to surpass US$ 600 million by 2033.

North America is the largest gamma knife market.

The main drivers are: rising obesity cases and implementation of imaging software.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2022 and Forecast, 2023-2033

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2022

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Disease Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Disease Indication, 2017-2022

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Indication, 2023-2033

        5.3.1. Brain Metastasis

        5.3.2. Cancer

        5.3.3. Arteriovenous Malformation

        5.3.4. Trigeminal Neuralgia

        5.3.5. Other Disease Indications

    5.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2022

    5.5. Absolute $ Opportunity Analysis By Disease Indication, 2023-2033

6. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Anatomy

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Anatomy, 2017-2022

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Anatomy, 2023-2033

        6.3.1. Head

        6.3.2. Neck

        6.3.3. Other Body Parts

    6.4. Y-o-Y Growth Trend Analysis By Anatomy, 2017-2022

    6.5. Absolute $ Opportunity Analysis By Anatomy, 2023-2033

7. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2022

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. APAC

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Disease Indication

        8.2.3. By Anatomy

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Disease Indication

        8.3.3. By Anatomy

    8.4. Key Takeaways

9. Latin America Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        9.2.1. By Country

            9.2.1.1. Argentina

            9.2.1.2. Brazil

            9.2.1.3. Mexico

            9.2.1.4. Rest of Latin America

        9.2.2. By Disease Indication

        9.2.3. By Anatomy

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Disease Indication

        9.3.3. By Anatomy

    9.4. Key Takeaways

10. Europe Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        10.2.1. By Country

            10.2.1.1. U.K.

            10.2.1.2. Germany

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Nordic

            10.2.1.7. Benelux

            10.2.1.8. Rest of Europe

        10.2.2. By Disease Indication

        10.2.3. By Anatomy

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Disease Indication

        10.3.3. By Anatomy

    10.4. Key Takeaways

11. APAC Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. India

            11.2.1.3. ASEAN

            11.2.1.4. Australia & New Zealand

            11.2.1.5. Rest of APAC

        11.2.2. By Disease Indication

        11.2.3. By Anatomy

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Disease Indication

        11.3.3. By Anatomy

    11.4. Key Takeaways

12. MEA Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Rest of MEA

        12.2.2. By Disease Indication

        12.2.3. By Anatomy

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Disease Indication

        12.3.3. By Anatomy

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2022

            13.1.2.1. By Disease Indication

            13.1.2.2. By Anatomy

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2022

            13.2.2.1. By Disease Indication

            13.2.2.2. By Anatomy

    13.3. Argentina

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2022

            13.3.2.1. By Disease Indication

            13.3.2.2. By Anatomy

    13.4. Brazil

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2022

            13.4.2.1. By Disease Indication

            13.4.2.2. By Anatomy

    13.5. Mexico

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2022

            13.5.2.1. By Disease Indication

            13.5.2.2. By Anatomy

    13.6. U.K.

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2022

            13.6.2.1. By Disease Indication

            13.6.2.2. By Anatomy

    13.7. Germany

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2022

            13.7.2.1. By Disease Indication

            13.7.2.2. By Anatomy

    13.8. France

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2022

            13.8.2.1. By Disease Indication

            13.8.2.2. By Anatomy

    13.9. Spain

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2022

            13.9.2.1. By Disease Indication

            13.9.2.2. By Anatomy

    13.10. Italy

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2022

            13.10.2.1. By Disease Indication

            13.10.2.2. By Anatomy

    13.11. Nordic

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2022

            13.11.2.1. By Disease Indication

            13.11.2.2. By Anatomy

    13.12. Benelux

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2022

            13.12.2.1. By Disease Indication

            13.12.2.2. By Anatomy

    13.13. Russia

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2022

            13.13.2.1. By Disease Indication

            13.13.2.2. By Anatomy

    13.14. Poland

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2022

            13.14.2.1. By Disease Indication

            13.14.2.2. By Anatomy

    13.15. China

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2022

            13.15.2.1. By Disease Indication

            13.15.2.2. By Anatomy

    13.16. India

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2022

            13.16.2.1. By Disease Indication

            13.16.2.2. By Anatomy

    13.17. ASEAN

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2022

            13.17.2.1. By Disease Indication

            13.17.2.2. By Anatomy

    13.18. Australia & New Zealand

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2022

            13.18.2.1. By Disease Indication

            13.18.2.2. By Anatomy

    13.19. Japan

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2022

            13.19.2.1. By Disease Indication

            13.19.2.2. By Anatomy

    13.20. GCC Countries

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2022

            13.20.2.1. By Disease Indication

            13.20.2.2. By Anatomy

    13.21. South Africa

        13.21.1. Pricing Analysis

        13.21.2. Market Share Analysis, 2022

            13.21.2.1. By Disease Indication

            13.21.2.2. By Anatomy

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Disease Indication

        14.3.3. By Anatomy

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Elekta

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Varian Medical Systems

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Huiheng Medical, Inc.

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Akesis, Inc.

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2033

Table 2: Global Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033

Table 3: Global Market Value (US$ Mn) Forecast by Anatomy, 2017-2033

Table 4: North America Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 5: North America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033

Table 6: North America Market Value (US$ Mn) Forecast by Anatomy, 2017-2033

Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 8: Latin America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033

Table 9: Latin America Market Value (US$ Mn) Forecast by Anatomy, 2017-2033

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 11: Europe Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033

Table 12: Europe Market Value (US$ Mn) Forecast by Anatomy, 2017-2033

Table 13: APAC Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 14: APAC Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033

Table 15: APAC Market Value (US$ Mn) Forecast by Anatomy, 2017-2033

Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 17: MEA Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033

Table 18: MEA Market Value (US$ Mn) Forecast by Anatomy, 2017-2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Disease Indication, 2023-2033

Figure 2: Global Market Value (US$ Mn) by Anatomy, 2023-2033

Figure 3: Global Market Value (US$ Mn) by Region, 2023-2033

Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2017-2033

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033

Figure 7: Global Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033

Figure 10: Global Market Value (US$ Mn) Analysis by Anatomy, 2017-2033

Figure 11: Global Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033

Figure 13: Global Market Attractiveness by Disease Indication, 2023-2033

Figure 14: Global Market Attractiveness by Anatomy, 2023-2033

Figure 15: Global Market Attractiveness by Region, 2023-2033

Figure 16: North America Market Value (US$ Mn) by Disease Indication, 2023-2033

Figure 17: North America Market Value (US$ Mn) by Anatomy, 2023-2033

Figure 18: North America Market Value (US$ Mn) by Country, 2023-2033

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 22: North America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033

Figure 23: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033

Figure 24: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033

Figure 25: North America Market Value (US$ Mn) Analysis by Anatomy, 2017-2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033

Figure 28: North America Market Attractiveness by Disease Indication, 2023-2033

Figure 29: North America Market Attractiveness by Anatomy, 2023-2033

Figure 30: North America Market Attractiveness by Country, 2023-2033

Figure 31: Latin America Market Value (US$ Mn) by Disease Indication, 2023-2033

Figure 32: Latin America Market Value (US$ Mn) by Anatomy, 2023-2033

Figure 33: Latin America Market Value (US$ Mn) by Country, 2023-2033

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 37: Latin America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033

Figure 40: Latin America Market Value (US$ Mn) Analysis by Anatomy, 2017-2033

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033

Figure 43: Latin America Market Attractiveness by Disease Indication, 2023-2033

Figure 44: Latin America Market Attractiveness by Anatomy, 2023-2033

Figure 45: Latin America Market Attractiveness by Country, 2023-2033

Figure 46: Europe Market Value (US$ Mn) by Disease Indication, 2023-2033

Figure 47: Europe Market Value (US$ Mn) by Anatomy, 2023-2033

Figure 48: Europe Market Value (US$ Mn) by Country, 2023-2033

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 52: Europe Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033

Figure 53: Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033

Figure 55: Europe Market Value (US$ Mn) Analysis by Anatomy, 2017-2033

Figure 56: Europe Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033

Figure 57: Europe Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033

Figure 58: Europe Market Attractiveness by Disease Indication, 2023-2033

Figure 59: Europe Market Attractiveness by Anatomy, 2023-2033

Figure 60: Europe Market Attractiveness by Country, 2023-2033

Figure 61: APAC Market Value (US$ Mn) by Disease Indication, 2023-2033

Figure 62: APAC Market Value (US$ Mn) by Anatomy, 2023-2033

Figure 63: APAC Market Value (US$ Mn) by Country, 2023-2033

Figure 64: APAC Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 65: APAC Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 66: APAC Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 67: APAC Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033

Figure 68: APAC Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033

Figure 69: APAC Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033

Figure 70: APAC Market Value (US$ Mn) Analysis by Anatomy, 2017-2033

Figure 71: APAC Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033

Figure 72: APAC Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033

Figure 73: APAC Market Attractiveness by Disease Indication, 2023-2033

Figure 74: APAC Market Attractiveness by Anatomy, 2023-2033

Figure 75: APAC Market Attractiveness by Country, 2023-2033

Figure 76: MEA Market Value (US$ Mn) by Disease Indication, 2023-2033

Figure 77: MEA Market Value (US$ Mn) by Anatomy, 2023-2033

Figure 78: MEA Market Value (US$ Mn) by Country, 2023-2033

Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 82: MEA Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033

Figure 83: MEA Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033

Figure 84: MEA Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033

Figure 85: MEA Market Value (US$ Mn) Analysis by Anatomy, 2017-2033

Figure 86: MEA Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033

Figure 87: MEA Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033

Figure 88: MEA Market Attractiveness by Disease Indication, 2023-2033

Figure 89: MEA Market Attractiveness by Anatomy, 2023-2033

Figure 90: MEA Market Attractiveness by Country, 2023-2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Mobile Gamma Cameras Market

Published : December 2021

Healthcare

Gamma Knife Market

Published : July 2021

Google translate